Martini B: [Lung cancer--epidemiology, prognosis and therapy]. Med Monatsschr Pharm. 2006, 29 (6): 217-21.
Zou T, Liu JY, She L, Yin JY, Li X, Li XP, Zhou HH, Chen J, Liu ZQ: The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Front Pharmacol. 2020, 11 (): 1029.
Li L, Zhou Q, Luo D, Xu Y, Yang H, Zhang S, Li A, Li H, Lv C: [A study on the relationship between lung cancer cell apoptosis and prognosis in patients with human non-small cell lung cancer.]. Zhongguo Fei Ai Za Zhi. 1998, 1 (2): 70-3.
Feng YY, Yang Y, Wang YY, Bai XX, Hai P, Zhao R: [Hypomethylation of DAPL1 associated with prognosis of lung cancer patients with EGFR Del19 mutation]. Zhonghua Zhong Liu Za Zhi. 2021, 43 (12): 1264-1268.
Xiao Y, Zhu S, Yin W, Liu X, Hu Y: IGFBP-4 expression is adversely associated with lung cancer prognosis. Oncol Lett. 2017, 14 (6): 6876-6880.
Lang J, Zhao Q, He Y, Yu X: Bone turnover markers and novel biomarkers in lung cancer bone metastases. Biomarkers. 2018, 23 (6): 518-526.
['Pambébasan: médis']
['Situs web puniki wantah kaanggén genah malajah miwah informasi, nénten dados genah ngicénin piteket utawi layanan medis.']
['Gatra sane kawedar nenten dados kaanggen anggen nyelehin utawi ngubadin pikobet utawi penyakit kesehatan, lan anake sane ngrereh piteket medis pribadi patut matemu ring dokter sane madue lisensi.']
['Elingang yéning jaringan saraf sané ngasilang pasaur ring pitakén, nénten akurat yéning indiknyané indik angka.']
['Tulung ja nunas piteket saking dokter utawi dokter sane sampun kualifikasi indik kahanan medis. Sampunang ja ngutang piteket saking dokter utawi nunda piteket santukan wenten sane sampun kawacen ring situs puniki. Yening wenten pikobet medis, gelis hubungi 911 utawi ka ruang gawat darurat sane nampek.']
['Sanggahan: hak cipta']
['Digital Millennium Copyright Act saking warsa 1998, 17 U.S.C. § 512 (DMCA) ngicenin hak antuk sang sane maduwe hak cipta sane percaya materi sane wenten ring internet nglanggar hak ipun manut undang-undang hak cipta AS. ']
['Yening semeton pracaya antuk manah sane becik indik daging utawi bahan sane kasayagayang ring situs utawi layanan titiang mamurug hak cipta semeton, semeton (utawi agen) dados ngirimang gatra ring titiang nunas daging utawi bahan punika kaicalang, utawi akses ka blokir.']
['Pangumuman patut katur antuk surat utawi email (cingak bagian "Kontak" antuk alamat email).']
['DMCA ngarsayang mangda gatra indik pelanggaran hak cipta sane kaaduang madaging informasi sane kawedar: (1) deskripsi karya sane kacakup hak cipta sane kaaduang dados subyek pelanggaran; (2) deskripsi konten sane kaaduang nglanggar hak cipta lan informasi sane jangkep anggen iraga ngerereh konten punika; (3) informasi kontak ragane, rumasuk alamat, nomor telepon, miwah alamat email; (4) pernyataan ragane sane madasar antuk kapracayan sane becik indik konten sane kaaduang nenten kaicen wewenang olih sang sane maduwe hak cipta, utawi agennyane, utawi antuk hukum napi manten; ']
['(5) pernyataan saking ragane, sane katanda tanganin antuk hukuman sumpah palsu, indik informasi ring notifikasi punika akurat lan ragane madue wewenang antuk ngukuhang hak cipta sane kaucap sampun dilanggar; ']
['miwah (6) tanda tangan fisik utawi elektronik saking sang sane maduwe hak cipta utawi anak sane madue kuasa ngamargiang pakaryan saking sang sane maduwe hak cipta. ']
['Yening nenten ngranjingang makasami informasi ring ajeng prasida ngawinang penanganan keluhan sayan sué.']
['Kontak sareng']
['Tulung kirim email antuk pitaken/usulan.']
What is prognosis of lung cancer?
The prognosis of lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the overall health of the patient.
Non-small cell lung cancer, which is the most common type, has a 5-year survival rate of about 18% for all stages combined.
However, if the cancer is caught early, the 5-year survival rate can be as high as 57%. Small cell lung cancer, which is less common, has a 5-year survival rate of about 7% for all stages combined.
It is important to note that these are general statistics and individual outcomes may vary.
Treatment options and advancements in medicine continue to improve, and many patients can live longer and have a better quality of life with proper care and management.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
